Format
Sort by
Items per page

Send to

Choose Destination

Links from Gene

Items: 1 to 20 of 554

1.

Cytosolic Sensors of Viral RNA Are Involved in the Production of Interleukin-6 via Toll-Like Receptor 3 Signaling in Human Glomerular Endothelial Cells.

Liu Q, Imaizumi T, Aizawa T, Hirono K, Kawaguchi S, Watanabe S, Tsugawa K, Matsumiya T, Seya K, Yoshida H, Tanaka H.

Kidney Blood Press Res. 2019;44(1):62-71. doi: 10.1159/000498837. Epub 2019 Feb 22.

2.

Toll-Like Receptor 3 Is Involved in Detection of Enterovirus A71 Infection and Targeted by Viral 2A Protease.

Chen KR, Yu CK, Kung SH, Chen SH, Chang CF, Ho TC, Lee YP, Chang HC, Huang LY, Lo SY, Chang JC, Ling P.

Viruses. 2018 Dec 5;10(12). pii: E689. doi: 10.3390/v10120689.

3.

Results of Detailed Investigations Into Stevens-Johnson Syndrome With Severe Ocular Complications.

Ueta M.

Invest Ophthalmol Vis Sci. 2018 Nov 1;59(14):DES183-DES191. doi: 10.1167/iovs.17-23537. Review.

PMID:
30481825
4.

Decreased TLR3 in Hyperplastic Adipose Tissue, Blood and Inflamed Adipocytes is Related to Metabolic Inflammation.

Latorre J, Moreno-Navarrete JM, Sabater M, Buxo M, Rodriguez-Hermosa JI, Girones J, Fort JM, Vilallonga R, Ricart W, Simo R, Fernandez-Real JM, Ortega FJ.

Cell Physiol Biochem. 2018;51(3):1051-1068. doi: 10.1159/000495487. Epub 2018 Nov 26.

5.

[Relationship of Toll Like Receptors Expression and HPV16 Infection in Cervical Squamous Cell Cancer].

Wang T, Qie MR.

Sichuan Da Xue Xue Bao Yi Xue Ban. 2018 Jul;49(4):649-651. Chinese.

PMID:
30378322
6.

Association between Toll-Like Receptor 3 (TLR3) rs3775290, TLR7 rs179008, TLR9 rs352140 and Chronic HCV.

Mosaad YM, Metwally SS, Farag RE, Lotfy ZF, AbdelTwab HE.

Immunol Invest. 2019 Apr;48(3):321-332. doi: 10.1080/08820139.2018.1527851. Epub 2018 Oct 15.

PMID:
30321082
7.

Human iPSC-derived trigeminal neurons lack constitutive TLR3-dependent immunity that protects cortical neurons from HSV-1 infection.

Zimmer B, Ewaleifoh O, Harschnitz O, Lee YS, Peneau C, McAlpine JL, Liu B, Tchieu J, Steinbeck JA, Lafaille F, Volpi S, Notarangelo LD, Casanova JL, Zhang SY, Smith GA, Studer L.

Proc Natl Acad Sci U S A. 2018 Sep 11;115(37):E8775-E8782. doi: 10.1073/pnas.1809853115. Epub 2018 Aug 28.

8.

Increased expression of toll-like receptor 3, an anti-viral signaling molecule, and related genes in Alzheimer's disease brains.

Walker DG, Tang TM, Lue LF.

Exp Neurol. 2018 Nov;309:91-106. doi: 10.1016/j.expneurol.2018.07.016. Epub 2018 Aug 1.

PMID:
30076830
9.

[REDUCED RESPONSE OF NATURAL KILLER LYMPHOCYTES TO TOLL-LIKE RECEPTOR 3 STIMULATION IN CHILDREN WITH RECURRENT INFECTIONS.]

Osypchuk DV, Chernyshov VP, Chernysheva LI, Kissel NP, Dons'koi BV, Matvienko IM, Rodionov VP, Makovs'ka YU.

Fiziol Zh. 2016;62(4):12-17. Ukrainian.

PMID:
29975469
10.

TLR2 and TLR3 expression as a biomarker for the risk of doxorubicin-induced heart failure.

Liang S, Xinyong C, Hongmin Z, Jing W, Lang H, Ping Z.

Toxicol Lett. 2018 Oct 1;295:205-211. doi: 10.1016/j.toxlet.2018.06.1219. Epub 2018 Jun 28.

PMID:
29959987
11.

Association of Toll-like receptor 3 and Toll-like receptor 9 single-nucleotide polymorphisms with hepatitis C virus persistence among Egyptians.

Hamdy S, Osman AM, Zakaria ZA, Galal I, Sobhy M, Hashem M, Allam WR, Abdel-Samiee M, Rewisha E, Waked I, Abdelwahab SF.

Arch Virol. 2018 Sep;163(9):2433-2442. doi: 10.1007/s00705-018-3893-8. Epub 2018 Jun 2.

PMID:
29860675
12.

Oxidative stress modulates the expression of toll‑like receptor 3 during respiratory syncytial virus infection in human lung epithelial A549 cells.

Wang MM, Lu M, Zhang CL, Wu X, Chen JX, Lv WW, Sun T, Qiu H, Huang SH.

Mol Med Rep. 2018 Aug;18(2):1867-1877. doi: 10.3892/mmr.2018.9089. Epub 2018 May 29.

PMID:
29845280
13.

Modulation of Mast Cell Toll-Like Receptor 3 Expression and Cytokines Release by Histamine.

Xie G, Wang F, Peng X, Liang Y, Yang H, Li L.

Cell Physiol Biochem. 2018;46(6):2401-2411. doi: 10.1159/000489646. Epub 2018 May 4.

14.

Crosstalk between Toll-like receptor 3 and Notch signaling contributes to CD14+ monocytes activity in enterovirus 71 infected hand, foot, and mouth disease.

Hao J, Li P, Tian Y, Wang Y, Li S, Wang L, Li S.

Int Immunopharmacol. 2018 Jul;60:26-33. doi: 10.1016/j.intimp.2018.04.031. Epub 2018 Apr 24.

PMID:
29702280
15.

Activation of TLR3 and its adaptor TICAM-1 increases miR-21 levels in extracellular vesicles released from human cells.

Fukushima Y, Okamoto M, Ishikawa K, Kouwaki T, Tsukamoto H, Oshiumi H.

Biochem Biophys Res Commun. 2018 Jun 7;500(3):744-750. doi: 10.1016/j.bbrc.2018.04.146. Epub 2018 Apr 23.

PMID:
29679565
16.

Recognition of Double-Stranded RNA and Regulation of Interferon Pathway by Toll-Like Receptor 10.

Lee SM, Yip TF, Yan S, Jin DY, Wei HL, Guo RT, Peiris JSM.

Front Immunol. 2018 Mar 16;9:516. doi: 10.3389/fimmu.2018.00516. eCollection 2018.

17.

Analysis of host Toll-like receptor 3 and RIG-I-like receptor gene expression in patients with abdominal aortic aneurysm.

Jabłońska A, Neumayer C, Bolliger M, Gollackner B, Klinger M, Paradowska E, Nanobachvili J, Huk I.

J Vasc Surg. 2018 Dec;68(6S):39S-46S. doi: 10.1016/j.jvs.2017.10.087. Epub 2018 Mar 19.

PMID:
29567028
18.

Secretion of Hepatitis C Virus Replication Intermediates Reduces Activation of Toll-Like Receptor 3 in Hepatocytes.

Grünvogel O, Colasanti O, Lee JY, Klöss V, Belouzard S, Reustle A, Esser-Nobis K, Hesebeck-Brinckmann J, Mutz P, Hoffmann K, Mehrabi A, Koschny R, Vondran FWR, Gotthardt D, Schnitzler P, Neumann-Haefelin C, Thimme R, Binder M, Bartenschlager R, Dubuisson J, Dalpke AH, Lohmann V.

Gastroenterology. 2018 Jun;154(8):2237-2251.e16. doi: 10.1053/j.gastro.2018.03.020. Epub 2018 Mar 11.

19.

Toll Like Receptor 3 Polymorphisms in Hepatitis B Virus Infection.

EzzEl-Din AM, Galal SH, Ahmed AO, Kamel SI, Kamal DT.

Egypt J Immunol. 2017 Jun;24(2):173-185.

PMID:
29528590
20.

Toll-like receptor 3 activation impairs excitability and synaptic activity via TRIF signalling in immature rat and human neurons.

Ritchie L, Tate R, Chamberlain LH, Robertson G, Zagnoni M, Sposito T, Wray S, Wright JA, Bryant CE, Gay NJ, Bushell TJ.

Neuropharmacology. 2018 Jun;135:1-10. doi: 10.1016/j.neuropharm.2018.02.025. Epub 2018 Mar 2.

Supplemental Content

Support Center